| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/09/2004 | US20040175380 Compositions and methods for modulating lymphocyte activity |
| 09/09/2004 | US20040175377 Agent and method for reducing intraocular pressure |
| 09/09/2004 | US20040175370 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175364 Gene transfer with adenoviruses having modified fiber proteins |
| 09/09/2004 | US20040175361 Modulator of desmosomal cadherin-mediated cell adhesion using a Trp(tryptophan)-containing cell adhesion recognition sequence; anticarcinogenic, antitumor, and antimetastasis agents |
| 09/09/2004 | US20040175359 Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
| 09/09/2004 | US20040175357 IL-2 selective agonists and antagonists |
| 09/09/2004 | US20040175356 Cysteine variants of interleukin-11 |
| 09/09/2004 | US20040175355 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals |
| 09/09/2004 | US20040173527 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/08/2004 | EP1455190A1 Modulation of the activity of nuclear receptors via EWS |
| 09/08/2004 | EP1455186A1 Screening method |
| 09/08/2004 | EP1454989A1 Infectious HCV pseudo-particles containing native functional E1 and E2 envelope proteins |
| 09/08/2004 | EP1454988A1 Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
| 09/08/2004 | EP1454987A1 Polypeptides translocated into cells by the VirB/VirD4 type IV secretion system and uses thereof |
| 09/08/2004 | EP1454985A2 Modulators of receptors of the tnf/ngf receptor family |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454982A1 Mtehod of analyzing gene expression |
| 09/08/2004 | EP1454981A1 Infectious pestivirus pseudo-particles containing functional erns, E1, E2 envelope proteins |
| 09/08/2004 | EP1454916A1 Modified cDNA factor VIII and its derivatives |
| 09/08/2004 | EP1454915A1 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454629A2 Insulinotrophic agent based on preproglucagon |
| 09/08/2004 | EP1454525A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE |
| 09/08/2004 | EP1454524A1 Hcv gene transgenic animal |
| 09/08/2004 | EP1454146A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 09/08/2004 | EP1454145A2 Method for the assessment and prognosis of sarcoidosis |
| 09/08/2004 | EP1454138A2 Immunocytokines with modulated selectivity |
| 09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
| 09/08/2004 | EP1453965A2 Dna vaccine |
| 09/08/2004 | EP1453964A2 Genes coding for stress resistance and tolerance proteins |
| 09/08/2004 | EP1453952A2 Compositions and methods for normalizing assays |
| 09/08/2004 | EP1453950A2 Nucleic acid molecules from rice encoding proteins for abiotic stress tolerance, enhanced yield, disease resistance and altered nutritional quality and uses thereof |
| 09/08/2004 | EP1453948A2 Cell culture process |
| 09/08/2004 | EP1453862A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 09/08/2004 | EP1453861A2 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 09/08/2004 | EP1453860A2 Novel glucose-dependant insulins |
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/08/2004 | EP1453858A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| 09/08/2004 | EP1453857A1 Chromatographic purification of recombinant human erythropoietin |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453854A2 Human cdnas and proteins and uses thereof |
| 09/08/2004 | EP1453853A2 Mixture of peptides originating from a nef protein and applications thereof |
| 09/08/2004 | EP1453608A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/08/2004 | EP1453553A1 Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453530A2 Method of proliferation in neurogenic regions |
| 09/08/2004 | EP1453471A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 09/08/2004 | EP1453467A2 Methods and compositions for modulating apoptosis |
| 09/08/2004 | EP1453383A2 A novel saitohin gene and uses of same |
| 09/08/2004 | EP1409510A4 Biological pacemaker |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | EP1177439B1 Screening for immunostimulatory dna functional modifiers |
| 09/08/2004 | EP1174501B1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 09/08/2004 | EP1141021B1 Removal/purification of serum albumins |
| 09/08/2004 | EP1131087B1 Methods of alleviating cancer symptoms |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1087995B1 A method for inducing production of growth factors |
| 09/08/2004 | EP1084261B1 Recombinant venezuelan equine encephalitis virus vaccine |
| 09/08/2004 | EP1053017B1 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 09/08/2004 | EP1017802B1 A potential effector for the grb7 family of signalling proteins |
| 09/08/2004 | EP0996708A4 Transgenic nematode model of triplet repeat neurological diseases |
| 09/08/2004 | EP0963163A4 Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5 %w/w |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0922099B1 Fas ligand-like protein, its production and use |
| 09/08/2004 | EP0870042B1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
| 09/08/2004 | EP0835127B1 Composition containing a myelin-associated glycoprotein (mag) inhibitor which comprises an altered or mutated form of mag |
| 09/08/2004 | EP0792284B1 Novel polypeptides |
| 09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 09/08/2004 | CN1527882A Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 09/08/2004 | CN1527880A Enhanced 2-keto-L-gulonic acid production |
| 09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG) |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same |
| 09/08/2004 | CN1527720A Global analysis of protein activities using proteome chips |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527663A Novel pesticidal toxins |
| 09/08/2004 | CN1526821A New glucoamylase and coding its nucleic acid sequence |
| 09/08/2004 | CN1526820A Promotor for expressing gene in fungal cell |
| 09/08/2004 | CN1526817A Anhydrant gene BcDh1 and the application of its promoter in raising drought-enduring plant |
| 09/08/2004 | CN1526732A Process for producing high pureness albumin solution |
| 09/08/2004 | CN1526731A Separation and purification process of recombinant human erythrogenin |
| 09/08/2004 | CN1526730A Erythrocytosis factor and its production process |
| 09/08/2004 | CN1526729A Method of separating and purifying recombinant cytochrome P450 bm-3 with hydrophobic chromatography as major means |
| 09/08/2004 | CN1526728A Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application |
| 09/08/2004 | CN1526727A Mouse tumor generating andmetastasis promoting acceptor and its encoding gene and application |
| 09/08/2004 | CN1526726A Multisite mutant of human histiotype plasminogen activator |
| 09/08/2004 | CN1165625C Fractionation of soybean 7s globulin and 11S globulin and process for producing the same |
| 09/08/2004 | CN1165618C Polynucleotide immunogenic agents |
| 09/08/2004 | CN1165613C Protein for inhancing tolerance of colibacillus to L-amino acid, coding gene and use thereof |
| 09/08/2004 | CN1165549C Process for rourifying insuline |